T2 Biosystems, Inc
TTOO
TTOO was delisted on the 11th of February, 2025.
21 hedge funds and large institutions have $1.37M invested in T2 Biosystems, Inc in 2023 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 23 closing their positions.
38% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 8
48% less funds holding
Funds holding: 40 → 21 (-19)
83% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 23
83% less capital invested
Capital invested by funds: $8.23M → $1.37M (-$6.87M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$396K |
| 2 |
VF
Virtu Financial
New York
|
+$77K |
| 3 |
Jane Street
New York
|
+$68.4K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
+$22.5K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$15.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BS
Banco Santander
Madrid,
Spain
|
-$4.18M |
| 2 |
BBA
Baader Bank Aktiengesellschaft
Unterschleissheim,
Germany
|
-$121K |
| 3 |
Northern Trust
Chicago,
Illinois
|
-$111K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$100K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$55.6K |
TTOO Hedge Fund Activity: Q4 2023 in Review
21 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in T2 Biosystems, Inc (TTOO) for Q4 2023, worth a combined $1.37M — down 83% from $8.23M a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of TTOO and 4 opened new positions — a net loss of 19 holders — while 8 trimmed existing stakes and 5 added.
The largest buyer was Susquehanna International Group, adding an estimated $396K. The largest seller was Banco Santander, exiting entirely with an estimated $4.18M sold.
- 21 institutional investors held T2 Biosystems, Inc (TTOO) as of Q4 2023, down from 40 in Q3 2023.
- Funds reported $1.37M of T2 Biosystems, Inc stock for Q4 2023, down 83% quarter-over-quarter.
- 4 funds opened new T2 Biosystems, Inc positions in Q4 2023 and 23 closed out, a net change of -19 holders.
- The largest T2 Biosystems, Inc buyer in Q4 2023 was Susquehanna International Group, an estimated $396K added.
- The largest T2 Biosystems, Inc seller in Q4 2023 was Banco Santander, an estimated $4.18M sold.
Based on aggregated 13F filings for Q4 2023.